Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Bergin

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
International Journal of STD & AIDS|September 27, 2021
A changing demographic - Ten years of HIV careNadra Nurdin, Siobhan Quirke, Colm Kerr, et al.
Pharmacogenetics and Genomics|April 9, 2010
An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in EuropeChloe Orkin, Jianmin Wang, Colm Bergin, et al.
BMC Infectious Diseases|October 28, 2015
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional studyJennifer Ann Kieran, Suzanne Norris, Aisling O'Leary, et al.
Travel Medicine and Infectious Disease|December 16, 2021
Delayed haemolysis after IV artesunate therapy for P. falciparum infectionRòisìn O'Connor, Ciara Conlan, Conor Grant, et al.
AIDS Research and Human Retroviruses|July 21, 2011
Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008Cillian F De Gascun, Allison Waters, Ciara Regan, et al.
Jac-Antimicrobial Resistance|June 30, 2021
Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infectionLiam Townsend, Gerry Hughes, Colm Kerr, et al.
The Journal of Infection|August 13, 2021
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individualsNiamh Allen, Melissa Brady, Antonio Isidro Carrion Martin, et al.
The Journal of Infection|September 30, 2015
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programmeAndrea Gori, Manuela Doroana, Oksana Chernova, et al.
AIDS Research and Human Retroviruses|December 20, 2011
Human immunodeficiency virus type 1 in Ireland: phylogenetic evidence for risk group-specific subepidemicsCillian F De Gascun, Allison Waters, Ciara M Regan, et al.
Plos One|February 6, 2013
Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden countryClíona Ní Cheallaigh, Ian Fitzgerald, Jacinta Grace, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
International Journal of STD & AIDS|September 27, 2021
A changing demographic - Ten years of HIV careNadra Nurdin, Siobhan Quirke, Colm Kerr, et al.
Pharmacogenetics and Genomics|April 9, 2010
An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in EuropeChloe Orkin, Jianmin Wang, Colm Bergin, et al.
BMC Infectious Diseases|October 28, 2015
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional studyJennifer Ann Kieran, Suzanne Norris, Aisling O'Leary, et al.
Travel Medicine and Infectious Disease|December 16, 2021
Delayed haemolysis after IV artesunate therapy for P. falciparum infectionRòisìn O'Connor, Ciara Conlan, Conor Grant, et al.
AIDS Research and Human Retroviruses|July 21, 2011
Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008Cillian F De Gascun, Allison Waters, Ciara Regan, et al.
Jac-Antimicrobial Resistance|June 30, 2021
Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infectionLiam Townsend, Gerry Hughes, Colm Kerr, et al.
The Journal of Infection|August 13, 2021
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individualsNiamh Allen, Melissa Brady, Antonio Isidro Carrion Martin, et al.
The Journal of Infection|September 30, 2015
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programmeAndrea Gori, Manuela Doroana, Oksana Chernova, et al.
AIDS Research and Human Retroviruses|December 20, 2011
Human immunodeficiency virus type 1 in Ireland: phylogenetic evidence for risk group-specific subepidemicsCillian F De Gascun, Allison Waters, Ciara M Regan, et al.
Plos One|February 6, 2013
Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden countryClíona Ní Cheallaigh, Ian Fitzgerald, Jacinta Grace, et al.
Pageof 14